Skip to main content
logo
Soleno Therapeutics, Inc. (SLNO)
NASDAQ: SLNO · Real-Time Price · USD
31.72
-1.50 (-4.52%)
At close: Mar 23, 2026, 4:00 PM EDT
31.70
-0.02 (-0.06%)
After-hours: Mar 23, 2026, 7:52 PM EDT

Soleno Therapeutics Revenue

In the year 2025, Soleno Therapeutics had annual revenue of $190.41M. Soleno Therapeutics had revenue of $91.73M in the quarter ending December 31, 2025.

Revenue (ttm)
$190.41M
Revenue Growth
n/a
P/S Ratio
8.60
Revenue / Employee
$1,046,181
Employees
182
Market Cap
1.64B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025190.41M--
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Novavax1.12B
Harmony Biosciences Holdings868.45M
Innoviva411.33M
Immunocore Holdings400.02M
Vericel276.26M
Recursion Pharmaceuticals74.68M
Intellia Therapeutics67.67M
Agios Pharmaceuticals54.03M
Revenue Rankings

SLNO News

More News